Related Experiment Video
Updated: Jun 4, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases
Andreu Llorente1, Ignacio Perez-Valero, E García
1Servicio de Hematología, Hospital Joan XXIII, IISPV, Tarragona, Spain. allorente.hj23.ics@gencat.cat
Aim:
To investigate mortality risk factors in patients with zygomycosis.
Patients And Methods:
Retrospective case history review of patients diagnosed with proven zygomicosis in 17 centres in Spain. We compared demographics and risk factors in patients who survived, and in those who died.
Results:
We identified twenty-five patients with proven zygomycosis. The primary site of infection was rhino-orbito-cerebral (28%) and disseminated (20%) or cutaneous/soft infections (20%) of the patients. Eleven patients (44%) received preemptive or empirical antifungal treatment; of these patients, 4 received liposomal amphotericin B, 1 received amphotericin B lipid complex, and 6 received other antifungals. The overall mortality rate was 72%. In the univariate analysis factors associated with an increased risk of death were the presence of a haematological malignancy (P=.03), neutropenia (P=.03) and monocytopenia (P=.008).
Conclusion:
Our study supports previous research that has documented a high mortality rate among patients with invasive zygomycosis, especially among those with an underlying haematological malignancy, and the need for a rapid initiation of an effective antifungal treatment.
Related Concept Videos
Fungal Group Zygomycota
Cryptococcal Meningitis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Fungal Phylum Microsporidia
Candidiasis

